e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Intervening in allergic asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of sublingual allergen-specific therapy on asthma control and quality of life
D. Nagatkin, Z. Alexandr, J. Bogdanova, O. Nagatkina (Samara, Russian Federation)
Source:
International Congress 2014 – Intervening in allergic asthma
Session:
Intervening in allergic asthma
Session type:
Poster Discussion
Number:
3475
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Nagatkin, Z. Alexandr, J. Bogdanova, O. Nagatkina (Samara, Russian Federation). The impact of sublingual allergen-specific therapy on asthma control and quality of life. Eur Respir J 2014; 44: Suppl. 58, 3475
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The impact of psychological distress on allergic rhinitis and asthma control
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Association between control of rhinitis and control of asthma as assessed by validated questionnaires
Source: International Congress 2014 – Clinical allergy
Year: 2014
Influence of maternal bronchial asthma clinical phenotype on development of allergies in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Assessment of mis-beliefs about bronchial asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Features of asthma treatment while pregnancy
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Evaluating omalizumab persistency of response after long-term therapy (XPORT)
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Omalizumab reduces exacerbations and healthcare utilisation in severe allergic asthma patients UK clinical practice - APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Efficacy of omalizumab in Polish real-world patients
Source: International Congress 2016 – Asthma management
Year: 2016
First clinical trial of a new IgE-adsorber in allergic asthma
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Predictors factors for asthma in patients with rhinitis
Source: International Congress 2014 – Clinical allergy
Year: 2014
Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Five-year clinical study of children with atopic asthma
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept